SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients.
about
Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profilingRobust estimation of the expected survival probabilities from high-dimensional Cox models with biomarker-by-treatment interactions in randomized clinical trials.Developing and characterization of single chain variable fragment (scFv) antibody against frizzled 7 (Fzd7) receptor.SOX4 contributes to the progression of cervical cancer and the resistance to the chemotherapeutic drug through ABCG2SOXC Genes and the Control of Skeletogenesis.GALNT14 promotes lung-specific breast cancer metastasis by modulating self-renewal and interaction with the lung microenvironmentHistological and Pathological Assessment of miR-204 and SOX4 Levels in Gastric Cancer Patients.GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancer.SOX4 promotes melanoma cell migration and invasion though the activation of the NF-κB signaling pathway.MiR-211 inhibits cell proliferation and invasion of gastric cancer by down-regulating SOX4.MicroRNA-204 inhibits cell proliferation in T-cell acute lymphoblastic leukemia by down-regulating SOX4.Overexpression of SOX4 correlates with poor prognosis of acute myeloid leukemia and is leukemogenic in zebrafishMicroRNA-338-3p targets SOX4 and inhibits cell proliferation and invasion of renal cell carcinoma.DownRegulated SOX4 Expression Suppresses Cell Proliferation, Migration, and Induces Apoptosis in Osteosarcoma In Vitro and In Vivo.[Role of SOX4 on DDP Resistance in Non-small Cell Lung Cancer Cell of A549].P53-miR-191-SOX4 regulatory loop affects apoptosis in breast cancer.Over-expression of Sox4 and β-catenin is associated with a less favorable prognosis of osteosarcoma.Cancer cell specific inhibition of Wnt/β-catenin signaling by forced intracellular acidification.
P2860
Q26781643-13ADD3F7-3C36-409D-B106-975D61FD6223Q33717226-254AC405-A0CA-4170-AE97-49DCFC58D560Q36193805-6D99D1E3-18CF-4356-9F79-BC425FDF9000Q36349907-E718DE7D-707C-4C5B-9A89-363C8833C871Q36669685-27CBE054-28AC-411D-AD80-02C7E345DEA0Q37519157-244A95EB-94D3-4C3D-AD59-092B7BA5A63AQ37590870-FB8501E3-E35B-4CF2-AE7F-BD99927B5B6BQ38408978-6AD8E030-F684-4557-83D4-73EB422F30DEQ38719562-19C056CF-B3D6-4AC9-98A3-AB90D8AEAAF2Q38798471-9B0AD0AE-426A-4FF0-A55B-BD6693320E6FQ38828046-D13D2F06-B018-4CB5-B57B-5B91B871F5F0Q41177054-E5ABA7F7-850D-4143-A1D6-CE4B6F38C09BQ47137081-624DF0E3-E326-48D9-BD7C-DE265F08B117Q47642773-174E2631-51DF-4AD2-A1F3-60C7F46AEC6EQ50630893-BFFF3B6F-6D25-4078-8241-DD33DA8E7F07Q50898952-FFB8D4A3-C3C1-45C2-8C9E-131C7303C2A2Q53123322-A973BAB4-5EAC-40C7-9544-169C3E3C518EQ55416886-CC3B0E76-7F3E-4978-A64D-C203921978DD
P2860
SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
SOX4 overexpression is a novel ...... sis in breast cancer patients.
@en
SOX4 overexpression is a novel ...... sis in breast cancer patients.
@nl
type
label
SOX4 overexpression is a novel ...... sis in breast cancer patients.
@en
SOX4 overexpression is a novel ...... sis in breast cancer patients.
@nl
prefLabel
SOX4 overexpression is a novel ...... sis in breast cancer patients.
@en
SOX4 overexpression is a novel ...... sis in breast cancer patients.
@nl
P2093
P2860
P1433
P1476
SOX4 overexpression is a novel ...... sis in breast cancer patients.
@en
P2093
P2860
P2888
P304
P356
10.1007/S13277-015-3051-9
P577
2015-01-16T00:00:00Z